Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Silver_Bullet who wrote (9282)	10/14/2002 9:41:01 PM
From: xcr600	Respond to of 48461

<<Who needs "terrorists" when all our meat is processed in one plant to "save costs" by consolidation. The companies that run them do enough to cause alarm and terror if not death to the public.>> Excellent point. I was going to post that article as well. What's even more amazing, is this is the same industry that has spent millions lobbying Congress for self regulation. God forbid what happens when that occurs.. it's scary enough the way it is now.

To: Silver_Bullet who wrote (9282)	10/15/2002 9:58:03 AM
From: Bucky Katt	Respond to of 48461

The terrorism attack in Bali is cause for alarm, to say the least. I don't see how this can be contained, so prepare for more life-style changes as we adjust to the new world order...(disorder?) That said, I am back from the UK. Security ar Heathrow was a real treat. They are at threat level "cobra" which means I went through 3, yes 3 security checkpoints..Flying just isn't what it used to be. But I happened to bitch to the right person at the gate, as I had to go through another sniffer/metal detector (at the gate) and was rewarded with a 1st class upgrade due to my dry humor, and they had a few open seats anyway. I see this stock is still making rat money... Message 16993201 And since you mentioned the new meat scare, I will mention this one again, I doubt it will get much cheaper, and if/when the FDA/industry starts using these on site test kits we could get a run similar to MDFT, (see above) which would be quite nice. xtrana.com Also note old rat BLUD in this link...It is still up near $20 And note in the above link they are getting some funding from DARPA, and I hope we all remember the other rats that have been getting funding from DARPA. Some backround> Extraction/Sample Preparation - Total annual sales of reagents for the preparation and purification of nucleic acids in 2001 was estimated to be $760 million, and is expected to grow to over $1.3 billion annually by the year 2005. Clinical Diagnostics - The total annual sales of all clinical diagnostic applications was estimated to be in excess of $21 billion in 2001. Of this total, nucleic acid based diagnostics represented approximately 7% or $1.5 billion. It is anticipated that the total clinical diagnostics industry will grow to over $35 billion by the year 2005. The nucleic acid segment is expected to grow at a much more rapid rate as new technologies enable new testing and cannibalize old testing methodologies. Biological Warfare Agent Detection - The current and future size of this market are unknown at this time, but clearly this is an area of anticipated growth in the area of nucleic acid diagnostics. Probably the best .20 lottery ticket around....

To: Silver_Bullet who wrote (9282)	10/15/2002 5:09:44 PM
From: Bucky Katt	Read Replies (2) \| Respond to of 48461

Anyone think the past 4 days of buying might be related to the fact that many funds close out their fiscal year at the end of Oct?

To: Silver_Bullet who wrote (9282)	10/16/2002 9:57:43 AM
From: Bucky Katt	Read Replies (3) \| Respond to of 48461

This will shock everyone who reads it, and goes to point regarding how full of sh*t govt stats really are. I have been watching over the past few years as more and more friends & family have been dying of cancer, so why are govt stats so heavily off base? New Statistics Show Increase, Not Decline, in Cancer Rates By SHARON BEGLEY Staff Reporter of THE WALL STREET JOURNAL America isn't winning the war on cancer after all. Contrary to optimistic reports from the National Cancer Institute showing the incidence of several devastating cancers has leveled off or even declined in recent years, rates for at least some of those cancers has been rising, according to a new analysis by NCI scientists. Previous indications of a decline reflected significant delays in reporting cancer cases, the researchers report Wednesday in the Journal of the National Cancer Institute. More accurate information about cancer rates presents a grimmer picture. "Maybe we were a little too eager to declare the effectiveness of our intervention and prevention programs," says Brenda Edwards, who is associate director for the surveillance research program at NCI, of Bethesda, Md., but wasn't among the authors of the new study. The revised estimates present a dispiriting picture of the nation's progress in preventing cancer. Breast-cancer rates in white women had been almost flat since 1987, according to the original NCI figures, which the American Cancer Society also uses as the basis for the popular "facts and figures" on its Web site. The reanalysis shows that breast-cancer rates actually have been rising 0.6% a year since 1987. That prompted the NCI scientists to call for research "to explain the cause for the recent rise in breast cancer incidence." Lung cancer in women also had been believed to be flat; the re-analysis shows it has been rising 1.2% a year since 1996. Melanoma rates in white males had reportedly been flat or even falling. The new analysis finds it has been soaring 4.1% a year since 1981, suggesting that prevention strategies that focus on staying out of the sun are falling short. Prostate-cancer rates in white males, rather than falling since 1995, have in fact been rising 2.2% a year. For white men, 1998 prostate-cancer rates are actually 12% higher than originally reported; for black men they are 14% higher. Colorectal cancer cases for both genders and all races are 3% higher than first reported, suggesting that early-screening techniques (which focus on discovering precancerous polyps through colonoscopies) aren't as powerful or widely used as hoped. The rate of colorectal cancer in white women, for instance, has been rising 2.8% annually since 1996, rather than the originally calculated 0.9%. National incidence data are based on reports from 10 registries in the SEER (Surveillance, Epidemiology, and End Results) program at NCI, which samples 14% of the U.S. population by collecting cancer reports from hospitals, doctors and clinics. The registries have 19 months to report cases to NCI. Scientists had long suspected that the original numbers were skewed. "It was well known that reports of new cancer cases dribbled in over the years, long after the 19-month reporting deadline," says Benjamin Hankey, the senior author of the study. So, researchers wondered, just how sharply did late reporting affect the final cancer-rate statistic for a specific year? Using data from 1981 to 1998, scientists led by Mr. Hankey analyzed reporting delays by counting how many additions nine registries made to their original count over the years. Based on that, but allowing for improvement in the timeliness and accuracy of the reports, NCI statistician Limin Clegg estimated the under-reports from each registry for five types of cancer. The delays are such that initial reports account for only 88% to 97% of the actual cancer cases, depending on the type, finds Dr. Clegg. That has left a "false impression of a recent decline in cancer incidence," write the NCI scientists. NCI's cancer-incidence rates are the basis for decisions by policy makers and clinicians alike: The numbers are used to allocate research and clinical resources, to give people a sense of their risk for various cancers and to offer hints about environmental causes of cancer ranging from use of sunblock to changes in diet and cumulative exposure to toxic chemicals. Now researchers feel a renewed urgency to study why the rates of several cancers are still on the rise. "This tells us something we didn't know about whether our intervention and prevention programs are working," says Ahmedin Jemal, director of the surveillance program for the American Cancer Society.

To: Silver_Bullet who wrote (9282)	10/16/2002 7:44:32 PM
From: Bucky Katt	Read Replies (1) \| Respond to of 48461

Anyone note the move old rat SURE made on food safety news? SAN DIEGO, Oct 16 (Reuters) - Shares of Surebeam Corp. (SURE,Trade), a provider of electronic beam food safety systems, on Wednesday soared more than 30 percent after the company won its latest grocery contract amid concern over meat safety following several U.S. outbreaks of food-borne illnesses. Surebeam, based in San Diego, California, said that it had secured a contract with the Price Chopper grocery chain in the Northeast, providing fresh meat treated with so-called "cold pasteurization," a form of irradiation, for 102 groceries. Shares in Surebeam, whose electron beam and X-ray technology destroys harmful food-borne bacteria such as listeria and E-coli, were up 60 cents, or 29.7 percent, to $2.62 in late Nasdaq trading on Wednesday. Earlier the shares touched $2.75. Analysts said news of the Price Chopper contract, which comes on the heels of a similar deal with Pathmark stores, is a hopeful sign that business is picking up for Surebeam, whose stock had been depressed after little progress in the first eight months of the year. They estimate that ground beef treated with Surebeam technology is now available in nearly 600 stores nationwide, up from little more than 60 in August. "We expect to see some substantive progress on those (new contracts) fronts in the coming months," said A.G. Edwards & Sons analyst Mark Jordan, who rates the shares a "buy." Also fueling potential for the technology is heightened consumer awareness over food-borne illnesses, particularly in meats and poultry. Earlier this week, U.S. poultry giant Pilgrim's Pride Corp. (CHX,Trade) recalled 27.4 million pounds of fresh and frozen ready-to-eat turkey and chicken under its Wampler brand. Federal health officials linked some of the product to an outbreak of listeria in the Northeast. In September, agribusiness giant Cargill Inc. recalled about 400,000 pounds of beef after federal authorities linked it to an E. coli outbreak in the Midwest. And in July, ConAgra Foods Inc. (CAG,Trade) recalled some 19 million pounds of ground beef due to E. coli contamination. "Clearly the recall by Pilgrim's Pride highlights the fact that there is a meaningful food problem out there that irradiation can address," Jordan said.